drugset / Trial / NCT03395548
Stability of the Microbiome in IBD and IBS
Non-randomizedParallel-groupOpen-labelBasic science
Summary
In this study the investigators aim to investigate the changes of the intestinal microbiome in three different cohorts (IBD, IBS, healthy) after applying the uniform disruptive factor of osmotic diarrhea induced by macrogol. The investigators hypothesis is that ill people will show more severe changes of the microbiome than healthy people and that these changes persist longer.
Timeline
- Start
- 2017-08-25
- Primary completion
- 2020-05-01
- Completion
- 2020-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Polyethylene Glycols | Unknown | — | Other |
Indications
No indication recorded.